IRIS
COSTANZO, ANTONIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.739
AS - Asia 4.919
EU - Europa 1.924
SA - Sud America 1.484
AF - Africa 307
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 18
AN - Antartide 1
Totale 19.418
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.542
SG - Singapore 2.952
BR - Brasile 1.282
CN - Cina 1.046
FI - Finlandia 376
IE - Irlanda 326
VN - Vietnam 274
NG - Nigeria 225
IT - Italia 222
DE - Germania 206
FR - Francia 159
GB - Regno Unito 154
HK - Hong Kong 152
CA - Canada 119
NL - Olanda 115
IN - India 112
AR - Argentina 74
SE - Svezia 67
TR - Turchia 64
BD - Bangladesh 55
BE - Belgio 53
MX - Messico 51
RU - Federazione Russa 49
EC - Ecuador 42
ES - Italia 41
ID - Indonesia 36
ZA - Sudafrica 35
UA - Ucraina 30
JP - Giappone 29
IL - Israele 26
PL - Polonia 25
IQ - Iraq 24
PK - Pakistan 21
AU - Australia 18
CL - Cile 18
CO - Colombia 18
JO - Giordania 18
UZ - Uzbekistan 16
CZ - Repubblica Ceca 15
PE - Perù 15
VE - Venezuela 13
RO - Romania 12
A2 - ???statistics.table.value.countryCode.A2??? 11
PY - Paraguay 11
TN - Tunisia 11
KR - Corea 10
SA - Arabia Saudita 10
AZ - Azerbaigian 8
DO - Repubblica Dominicana 8
EG - Egitto 7
MA - Marocco 7
NZ - Nuova Zelanda 7
AE - Emirati Arabi Uniti 6
CH - Svizzera 6
IR - Iran 6
LT - Lituania 6
PH - Filippine 6
AT - Austria 5
BG - Bulgaria 5
DK - Danimarca 5
DZ - Algeria 5
GR - Grecia 5
JM - Giamaica 5
KE - Kenya 5
NO - Norvegia 5
NP - Nepal 5
PT - Portogallo 5
RS - Serbia 5
UY - Uruguay 5
AL - Albania 4
KG - Kirghizistan 4
MD - Moldavia 4
OM - Oman 4
PA - Panama 4
PS - Palestinian Territory 4
SK - Slovacchia (Repubblica Slovacca) 4
TW - Taiwan 4
XK - ???statistics.table.value.countryCode.XK??? 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
BN - Brunei Darussalam 3
EU - Europa 3
HU - Ungheria 3
KZ - Kazakistan 3
QA - Qatar 3
TH - Thailandia 3
AO - Angola 2
BF - Burkina Faso 2
BO - Bolivia 2
EE - Estonia 2
ET - Etiopia 2
GA - Gabon 2
GE - Georgia 2
GT - Guatemala 2
GY - Guiana 2
KH - Cambogia 2
KW - Kuwait 2
LV - Lettonia 2
MT - Malta 2
MY - Malesia 2
Totale 19.395
Salva come PNG Salva come JPEG
Città #
Chandler 1.695
Wilmington 1.445
Singapore 794
The Dalles 708
Shanghai 670
Ashburn 594
San Mateo 575
Dallas 469
Ann Arbor 453
Helsinki 373
Boardman 355
Dublin 325
Lawrence 261
Princeton 261
Leawood 259
Benin City 223
New York 220
Beijing 202
Fairfield 146
Hong Kong 146
Woodbridge 131
Paris 129
São Paulo 112
Ho Chi Minh City 108
Amsterdam 93
Los Angeles 85
London 68
Seattle 66
Milan 65
Santa Clara 53
Toronto 53
Brussels 50
Phoenix 48
Hanoi 46
San Diego 42
Belo Horizonte 38
Council Bluffs 37
Rio de Janeiro 34
Falls Church 33
Brooklyn 29
Chennai 28
Kocaeli 28
Tokyo 27
Norwalk 25
Chicago 23
Houston 23
San Francisco 23
Johannesburg 22
Warsaw 21
Manchester 20
Montreal 19
Munich 19
Columbus 18
Guarulhos 17
Amman 16
Goiânia 16
Redmond 16
Tashkent 16
Campinas 15
Curitiba 15
Moscow 15
Salvador 15
Atlanta 13
Boston 13
Orem 13
Poplar 13
Sorocaba 13
Stockholm 13
Charlotte 12
Falkenstein 12
Lima 12
New Delhi 12
Porto Alegre 12
Quito 12
Brno 11
Guayaquil 11
Rome 11
Brasília 10
Haiphong 10
Jakarta 10
Buenos Aires 9
Des Moines 9
Fortaleza 9
Istanbul 9
Pune 9
Baku 8
Can Tho 8
Da Nang 8
Dronten 8
Duncan 8
Medellín 8
Mexico City 8
Naples 8
San Jose 8
São Bernardo do Campo 8
Abbiategrasso 7
Calgary 7
Carapicuíba 7
Caxias do Sul 7
Hanover 7
Totale 12.304
Salva come PNG Salva come JPEG
Nome #
Living with Chronic Spontaneous Urticaria in Italy: A Narrative Medicine Project to Improve the Pathway of Patient Care 320
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study 236
Melanoma in Adolescents and Young Adults (AYAs): An Italian Multi-Centric Retrospective Experience 187
CD28 costimulation regulates FOXP3 in a RelA/NF-κB-dependent mechanism. 127
y Clinical similarity of the biosimilar ABP 501 compared with adalimumab after single transition: long-term results from a randomized controlled, double-blind, 52-week, phase III trial in patients with moderate-to-severe plaque psoriasis 107
Chronic Hand Eczema (CHE): A Narrative Review 104
Rosacea-like Acute Reaction After Hyaluronic Acid Dermal Filler 100
A head-to-head comparison of the efficacy and safety of ixekizumab and adalimumab in biological-naive patients with active psoriatic arthritis: 24-week results of a randomised, open-label, blinded-assessor trial 98
Adalimumab for severe psoriasis and psoriatic arthritis: An open-label study in 30 patients previously treated with other biologics 98
Actinic keratosis treated with an immune response modifier: a case report of six patients 95
'Living with chronic urticaria': a study through narrative medicine to improve the quality of care 93
IL-21 in the pathogenesis and treatment of skin diseases. 92
Brodalumab: a new way to inhibit IL-17 in psoriasis 90
A feedback regulatory loop between p63 and Dlx3: implications for epidermal differentiation 89
Herpes simplex virus disrupts NF-kappa B regulation by blocking its recruitment on the I kappa B alpha promoter and directing the factor on viral genes 89
Nail Assessment in Psoriasis and Psoriatic Arthritis (NAPPA): development and validation of a tool for assessment of nail psoriasis outcomes. 89
How to make a skin-tight dress: the p63/claudin-1 connection 88
A symphony of regulations centered on p63 to control development of ectoderm-derived structures. 88
Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway 88
A role for the p63-IKKalpha pathway in the development of ectodermal dysplasias 88
A 48-week update of a multicentre real-life experience of dupilumab in adult patients with moderate-to-severe atopic dermatitis 88
A p38-dependent pathway regulates DNp63 DNA binding to p53 dependent promoters in UV-induced apoptosis of keratinocytes 86
Adalimumab for severe psoriasis and psoriatic arthritis: an open label study in 30 patients previously treated with other biologics 85
Efalizumab 84
Psoriasis: from pathogenesis to novel therapeutic approaches. 83
Functionalized gold nanoparticles for topical delivery of methotrexate for the possible treatment of psoriasis 82
A myogenic differentiation checkpoint activated by genotoxic stress 82
Topical use of valproic acid for the prevention or treatment of skin disorders 81
FGF8, c-Abl and p300 participate in a pathway that controls stability and function of the Delta Np63 alpha protein 80
A regulatory feedback loop involving p63 and IRF6 links the pathogenesis of 2 genetically different human ectodermal dysplasias 80
A role of p73 in mitotic exit 79
A fatal case of COVID-19 infection presenting with an erythema multiforme-like eruption and fever 79
A p38-dependent pathway regulates Delta Np63 DNA binding to p53-dependent promoters in UV-induced apoptosis of keratinocytes 78
Ustekinumab for treatment of plaque psoriasis in a patient with Down syndrome. 78
Age and gender influence on HIDRAdisk outcomes in adalimumab-treated hidradenitis suppurativa patients 78
Specific Infiltrate of Hodgkin Lymphoma at Site of Cellulitis Mimicking Secondary Cutaneous Involvement 78
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19 78
Zosteriform metastasis of occult bronchogenic carcinoma. 77
Adalimumab for the treatment of severe psoriasis and psoriatic arthritis 75
Long-term ustekinumab treatment for refractory type I pityriasis rubra pilaris. 75
Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta 75
p63 induces key target genes required for epidermal morphogenesis 74
The tumor suppressor activity of IKK alpha in stratified epithelia is exerted in part via the TGF-beta anti proliferative pathway 74
High-dose intravenous immunoglobulin for severe drug reactions: Efficacy in toxic epidermal necrolysis 74
Infliximab in psoriasis and psoriatic arthritis. 73
CD28 delivers a unique signal leading to the selective recruitment of RelA and p52 NF-kappa B subunits on IL-8 and Bcl-xL gene promotors 72
Noninferiority of biosimilar MSB110222 to reference adalimumab for chronic plaque psoriasis 72
IKKalpha downregulation in psoriasis: New insights in the pathway regulating keratinocyte proliferation 71
p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis 71
Keratosis punctata palmoplantaris and malignancies: Case report 71
Role of p63 in keratinocyte differentiation and proliferation 71
Treatment of psoriasis and psoriatic arthritis. 70
TRIM8 and p53: making the right decision. 70
Apoptotic, non-apoptotic, and anti-apoptotic pathways of tumor necrosis factor signalling 70
Role of the HLA-C(star)06 allele in clinical response to ustekinumab: evidence from real life in a large cohort of European patients 70
DNA Methylation Signature in Monozygotic Twins Discordant for Psoriatic Disease 69
c-E10 is a caspase-recruiting domain-containing protein that interacts with components of death receptors signaling pathway and activates nuclear factor-kappaB 69
Ashy dermatosis: clinico-pathological associations in two cases] 69
HLACw6 predisposes to clinical response to IL12/23 blocker ustekinumab: Results of short- and long-term treatment in anti-TNF naive patients 69
Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope 69
Prevalence and genomic variability of transfusion transmitted virus in Italian cryptogenic chronic liver disease and healthy blood donors. 69
Anti-IL17 and anti-IL23 biologic drugs for scalp psoriasis: A single-center retrospective comparative study 69
The p53/p63/p73 family of transcription factors: overlapping and distinct functions. . 2000 May;113 ( Pt 10):1661-70 68
p63-dependent and independent mechanisms of nectin-1 and -4 regulation in the epidermis. 68
Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target. 68
Elementi di dermatologia 67
Living Matter Observations with a Novel Hyperspectral Supercontinuum Confocal Microscope for VIS to Near-IR Reflectance Spectroscopy 66
The p73 gene is an anti-tumoral target of the RAR beta/gamma-selective retinoid tazarotene 66
Programmed cell death in the skin 66
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 66
Biomarkers to optimize ustekinumab therapy in psoriatic patients 66
Patient-relevant needs and treatment goals in nail psoriasis. 66
No metagenomic evidence of tumorigenic viruses in cancers from a selected cohort of immunosuppressed subjects 66
Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis. Gastroenterology. 1997 Oct;113(4):1384-9 66
Two new p73 splice variants, gamma and delta, with different transcriptional activity 65
Efficacy of short-term cyclosporine treatment to control psoriasis-related events during efalizumab therapy 65
Psychiatric comorbidity and suicidal ideation in psoriasis, melanoma and allergic disorders 65
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 65
Biologic therapies for plaque type psoriasis in patients with previous malignant cancer: long-term safety in a single- center real-life population 65
Systemic therapy of primary cutaneous B-cell lymphoma, marginal zone type, with rituximab, a chimeric anti-CD20 monoclonal antibody. 64
Delta Np63 knockdown mice: a mouse model for AEC syndrome 64
DNp73 alpha protects myogenic cells from apoptosis. 64
Histone deacetylases as new therapeutical targets for the treatment of Non-Melanoma Skin Cancer: results of phase I/IIa trial with topical DAC060 64
“Wide band reflectance spectral microscope and related spectral image method” 64
Apremilast for the treatment of palmo-plantar non-pustular psoriasis: A real-life single-center retrospective study 64
Professor Sergio Chimenti: 1949-2016 63
Baricitinib in Patients with Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Topical Corticosteroids: Results from Two Randomised Monotherapy Phase 3 Trials 63
Safety and efficacy study on etanercept in patients with plaque psoriasis 63
DLX5, FGF8 and the Pin1 isomerase control ΔNp63α protein stability during limb development: a regulatory loop at the basis of the SHFM and EEC congenital malformations. 63
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis 63
Pharmacogenetics of psoriasis: HLA-Cw6 but not LCE3B/3C deletion nor TNFAIP3 polymorphism predisposes to clinical response to interleukin 12/23 blocker ustekinumab 63
Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey 63
Clinical similarity of biosimilar ABP 501 to adalimumab in the treatment of patients with moderate to severe plaque psoriasis: A randomized, double-blind, multicenter, phase III study 62
Nuclear factor kB-independent cytoprotective pathways originating at tumor necrosis factor receptor-associated factor 2 62
Tumor necrosis factor (TNF) receptor 1 signaling downstream of TNF receptor-associated factor 2. Nuclear factor kappaB (NFkappaB)-inducing kinase requirement for activation of activating protein 1 and NFkappaB but not of c-Jun N-terminal kinase/stress-activated protein kinase 62
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA. 62
p63 and p73 transactivate differentiation gene promoters in human keratinocytes 62
Cutaneous and Mucosal Manifestations of Sjögren’s Syndrome 62
Psoriatic arthritis and CARD15 gene polymorphisms: no evidence for association in the Italian population. 61
Diagnosis and management of moderate to severe adult atopic dermatitis: a Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA) 61
Totale 7.976
Salva come PNG Salva come JPEG
Categoria #
all - tutte 151.838
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.838
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.491 0 0 0 0 0 803 361 188 504 358 3 274
2021/20221.472 49 12 19 323 21 38 57 195 143 111 413 91
2022/20234.235 595 166 374 543 399 390 5 353 790 319 242 59
2023/20242.627 158 237 592 68 54 222 174 416 44 54 211 397
2024/20254.125 107 80 45 64 66 427 260 396 571 981 533 595
2025/20264.553 1.601 690 667 1.004 392 199 0 0 0 0 0 0
Totale 19.687